efavirenz and Nervous System Disorders

efavirenz has been researched along with Nervous System Disorders in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arinaitwe, WJ; Khoo, S; Kiiza, D; Laker, E; Lamorde, M; Seden, K; Waitt, C	1
Best, BM; Capparelli, EV; Clifford, DB; Collier, AC; Ellis, R; Gelman, BB; Grant, I; Haubrich, R; Koopmans, PP; Letendre, SL; Mbeo, G; McCutchan, JA; Rossi, SS; Simpson, DM	1
Castagna, A; Duvivier, C; Gazzard, B; Hill, A; Marks, S; van Delft, Y; Zagler, C	1
Antinori, A; Boven, K; Clotet, B; Fourie, J; Herrera, G; Hicks, C; Madruga, JV; Mills, AM; Stevens, M; Vanveggel, S	1
Best, B; Capparelli, E; Goicoechea, M; Haubrich, R	1
Abo, Y; Anglaret, X; Anzian, A; Chenal, H; Danel, C; Eholié, S; Gabillard, D; Guehi, C; Moh, R; Rouet, F; Sorho, S	1
Everall, I; Gonzalez, A	1
Moyle, G	1

Reviews

1 review(s) available for efavirenz and Nervous System Disorders

Article	Year
Efavirenz: practicalities, considerations and new issues. International journal of clinical practice. Supplement, 1999, Volume: 103 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Humans; Lipodystrophy; Nervous System Diseases; Oxazines; Reverse Transcriptase Inhibitors	1999

Trials

3 trial(s) available for efavirenz and Nervous System Disorders

Article	Year
Phase 2 double-blind, randomized trial of etravirine versus efavirenz in treatment-naive patients: 48-week results. AIDS (London, England), 2011, Nov-28, Volume: 25, Issue:18 Topics: Adolescent; Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Double-Blind Method; Drug Resistance, Viral; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Young Adult	2011
Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks. HIV medicine, 2013, Volume: 14, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Humans; Mental Disorders; Middle Aged; Nervous System Diseases; Nitriles; Pyrimidines; Rilpivirine; Viral Load; Young Adult	2013
Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa. Journal of acquired immune deficiency syndromes (1999), 2006, Volume: 42, Issue:1 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Contraception; Cote d'Ivoire; Cyclopropanes; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; HIV-1; HIV-2; Humans; Male; Nervous System Diseases; Oxazines; Pregnancy; Pregnancy Complications; Transaminases; Treatment Outcome	2006

Other Studies

4 other study(ies) available for efavirenz and Nervous System Disorders

Article	Year
High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Drug Administration Schedule; Female; HIV Infections; Humans; Longitudinal Studies; Male; Mental Disorders; Nervous System Diseases; Outpatients; Prevalence; Prospective Studies; Risk Factors; Uganda	2018
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:2 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Brain; Chromatography, High Pressure Liquid; Cyclopropanes; Female; HIV Infections; Humans; Inhibitory Concentration 50; Male; Middle Aged; Nervous System Diseases; Random Allocation; Viral Load	2011
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jul-01, Volume: 43, Issue:1 Topics: Adult; Alkynes; Anti-HIV Agents; Anticonvulsants; Benzoxazines; Bipolar Disorder; Carbamazepine; Cyclopropanes; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; HIV Infections; Humans; Male; Mental Disorders; Nervous System Diseases; Oxazines; Oxcarbazepine; Treatment Failure; Viral Load	2006
Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (London, England), 1999, Oct-01, Volume: 13, Issue:14 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Nervous System Diseases; Oxazines; Reverse Transcriptase Inhibitors	1999